CE Certified Steel Cross-Type Membrane Valve Trocar for Reusable Surgical Instruments

FAQ

China's minimally invasive surgical technology leads the world

China's minimally invasive surgical technology has reached the leading level in the world. Starting from the first laparoscopic cholecystectomy in China in 1991, after more than 30 years of development, China's minimally invasive surgical technology has gone through a process from being suspected, accepted to being sought after, and gradually became an internationally leading technology. Especially in the fields of gastric cancer, intestinal cancer, liver cancer and pancreatic disease surgery, China's minimally invasive surgical technology has even surpassed the level of European and American countries.

In addition, China is also in the international leading position in the field of non-suspension pneumoperitoneum-free minimally invasive surgery, and it is likely to become an important part of my country's export of minimally invasive surgical technology. In recent years, China's minimally invasive surgical technology represented by NOSES (natural orifice surgery) has made great progress, and Chinese doctor teams have been active on the international medical stage, making the voice of Chinese medical innovation.

China's minimally invasive surgical technology has not only achieved remarkable achievements in China, but also demonstrated strong competitiveness and influence internationally, truly realizing from "nothing to something" and comparable to the international leading level.

What are the specific applications and results of China's minimally invasive surgical technology in gastric cancer, intestinal cancer, liver cancer and pancreatic disease surgery?

The specific applications and achievements of minimally invasive surgical techniques in China in gastric cancer, intestinal cancer, liver cancer and pancreatic disease surgery are as follows:

Gastric cancer:

Laparoscopic minimally invasive surgery has made significant progress in the treatment of gastric cancer in China. The research published by Professor Li Guoxin of Nanfang Hospital of Southern Medical University provided the first high-level evidence-based medical evidence for laparoscopic minimally invasive treatment of locally advanced gastric cancer, revealing its definite long-term efficacy and significant advantages.
The Chinese Laparoscopic Gastrointestinal Surgery Study Group (CLASS Study Group) has confirmed the safety and efficacy of laparoscopic surgery in locally advanced gastric cancer through a number of prospective multicenter studies, promoting the development of minimally invasive surgical treatment of gastric cancer.

In the past decade, a series of high-level clinical studies by the CLASS Study Group have led the paradigm innovation of minimally invasive surgical treatment of gastric cancer.

Intestinal cancer:

There is currently no direct evidence of China's specific applications and achievements in minimally invasive surgical techniques for intestinal cancer.

Liver cancer:

There is currently no direct evidence of China's specific applications and achievements in minimally invasive surgical techniques for liver cancer.

Pancreatic diseases:

Professor Mou Yiping and his team at Zhejiang Provincial People's Hospital have achieved remarkable results in minimally invasive surgery for pancreatic cancer, created an MDT model with minimally invasive surgery as the core, and summarized the development history and current status of laparoscopic pancreatic cancer surgery.

The team of Professor Chen Rufu of the Pancreatic Center has repeatedly set records in minimally invasive pancreatic surgery. More than 90% of pancreatic surgery patients can recover and be discharged within 10 days after surgery, and pancreatic cancer can be cured through peripancreatic nerve clearance.

Professor Zhang Taiping of Peking Union Medical College Hospital deeply interpreted minimally invasive treatment of pancreatic cancer and shared ten years of valuable experience in MDT diagnosis and treatment.

The Pancreatic Center of Guangdong Provincial People's Hospital successfully used "nanosecond knife" to treat advanced pancreatic cancer. This new technology does not generate heat energy during the ablation process and has the advantage of tissue and organ specific ablation.

What is the latest development of China's non-suspension pneumoperitoneum-free minimally invasive surgical technology, and how did it become internationally leading?

The latest development of China's non-suspension pneumoperitoneum-free minimally invasive surgical technology is mainly reflected in the following aspects:

This technology is in the international leading position in the field of non-suspension pneumoperitoneum-free minimally invasive surgery.

Application of pneumoperitoneum-free abdominal retractor: The pneumoperitoneum-free abdominal retractor invented by Professor Xue Yingwei, director of the Department of Gastrointestinal Surgery, Affiliated Cancer Hospital of Harbin Medical University, has been used in minimally invasive surgery for early gastric cancer since April last year. So far, 30 patients have successfully undergone pneumoperitoneum-free laparoscopic radical gastrectomy. This technology has not only obtained national invention patents and utility model patents, but also its effect is equivalent to traditional pneumoperitoneum laparoscopy.

Technical advantages and clinical applications: Pneumoperitoneum-free laparoscopic surgery mechanically lifts or arches the anterior abdominal wall to form an operating space, avoids pneumoperitoneum complications, increases surgical safety, and broadens the scope of application of laparoscopes. In addition, the pneumoperitoneum-free retractor eliminates the need for inflation in laparoscopic surgery, reduces trauma, and increases the speed of surgery.

What are the specific roles and contributions of NOSES (natural orifice surgery) in China's minimally invasive surgical technology?

NOSES (Natural Orifice Surgery) plays an important role in China's minimally invasive surgical technology and has made significant contributions, including the following aspects:

Technical innovation and promotion: The Chinese doctor team has made major breakthroughs in NOSES technology, pioneered this procedure, and through continuous technological innovation and promotion, this technology has been widely used. For example, major medical centers in China, such as Professor Wang Xishan's team and Professor Fu Chuangang's team, have successively carried out laparoscopic colorectal NOSES surgery.

Establishment of academic organizations: In order to promote the development and popularization of NOSES technology, China has established an academic organization centered on NOSES surgery - the China NOSES Alliance. The alliance is committed to sharing advanced NOSES technology with more primary medical institutions and benefiting a wider range of patients.

International exchanges and cooperation: The Chinese doctor team not only promotes NOSES technology in China, but also actively participates in international medical exchanges and voices Chinese medical innovation. Through cooperation with various countries, NOSES technology is expected to make new and greater contributions to the construction of a human health community.

Clinical application and effect: NOSES technology, as a minimally invasive surgical method, has been applied in many fields and has achieved good clinical results.

Policy support and guideline release: "Guidelines for Integrated Diagnosis and Treatment of Tumors in China (CACA)-NOSES Technology" is the world's first guideline for NOSES technology, which shows that NOSES technology has been supported and recognized at the policy level in China.

In recent years, in what aspects has the competitiveness and influence of China's minimally invasive surgical technology in the world been reflected?

In recent years, the competitiveness and influence of China's minimally invasive surgical technology in the world are mainly reflected in the following aspects:

International recognition of surgical technology: China's minimally invasive surgical team has demonstrated its superb laparoscopic surgical technology internationally and has been recognized and praised by foreign counterparts. For example, the minimally invasive surgical team of Ruijin Hospital demonstrated their technology at the 15th World Endoscopic Surgery Conference in 2016 and received high praise from international counterparts.

International exchanges and cooperation: China's minimally invasive surgical team has not only developed rapidly in China, but also actively gone abroad for technical exchanges and training. For example, the minimally invasive team of Ruijin Hospital went to Japan, India, France, Italy and other places to conduct surgical demonstrations between 2006 and 2010, guiding foreign doctors to perform laparoscopic surgery.

Technological innovation and leadership: China's minimally invasive surgical technology has made significant progress in many fields, especially in minimally invasive spine surgery.

Increased market competitiveness: Although China's minimally invasive surgical instrument market is currently dominated by foreign companies, with the continuous improvement of product technology and quality of domestic minimally invasive surgical instruments, the competitiveness of domestic brands is also gradually increasing. It is expected that in the next few years, domestic substitution will accelerate, and the competitive landscape of China's minimally invasive surgical instrument market will be adjusted.

Compared with European and American countries, what are the significant technological innovations or improvements in China's minimally invasive surgical technology?

Compared with European and American countries, China's minimally invasive surgical technology has shown significant technological innovations and improvements. The following are some specific performances:

Single-port laparoscopic surgical robot: Compared with traditional multi-port laparoscopic surgical robots, single-port laparoscopic surgical robots have the advantages of less trauma, no scars, and surgical beauty, and can adapt to narrow cavities. These characteristics make the operation more precise and beautiful.

Percutaneous spinal endoscopic technology: This technology has opened up the second revolutionary wave of minimally invasive spinal surgery in China.

"Tubeless" minimally invasive technology system for thoracic surgery: This technology pioneered by Chinese doctors is not only widely used in China, but also listed as a tutorial content by Harvard University, attracting foreign doctors to come and learn. This technical system realizes tubeless operation in thoracic surgery, further reducing patients' postoperative discomfort and recovery time.

Fusion innovation: At present, China's minimally invasive surgical technology is integrating with advanced technologies such as artificial intelligence to promote the development of minimally invasive surgery towards intelligence and remoteness. This integration not only improves the accuracy and safety of surgery, but also provides patients with more convenient medical services.

Iteration and upgrading of laparoscopic technology: Since 1991, China's laparoscopic technology has undergone countless technical iterations and has now reached the international leading level. This continuous technological innovation has enabled China to make significant progress in the field of minimally invasive surgery.

Minimally invasive treatment of heart valve disease: China has also made significant progress in the minimally invasive treatment of heart valve disease. Through a series of technical optimization and promotion and application, the safe and effective implementation of minimally invasive technology is guaranteed, and this technology has been promoted nationwide.

    
3 Packing & Shipping: